Interpretation of surgical treatment in Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition)
- VernacularTitle:《中华医学会肺癌临床诊疗指南（2019 版）》外科治疗解读
- Author:
Rui WANG
1
;
Feng YAO
1
;
Chunji CHEN
1
;
Wentao FANG
1
Author Information
1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P.R.China
- Publication Type:Journal Article
- Keywords:
Chinese Medical Association;
guidelines;
lung cancer;
surgical treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(11):1265-1268
- CountryChina
- Language:Chinese
-
Abstract:
With the increasing popularity of chest spiral CT screening, the detection rate of lung cancer in China is increasing. According to the characteristics of lung cancer in China and the progress of lung cancer researches at home and abroad, Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer are updated once a year. It is of great guiding significance to standardize and improve the clinical diagnosis and treatment of lung cancer for thoracic surgeons. The surgical diagnosis and treatment of lung cancer in the guidelines mainly include: (1) surgical treatment of stage Ⅰ-Ⅱ non-small cell lung cancer (NSCLC); (2) surgical treatment of resectable stage Ⅲ NSCLC; (3) surgical treatment of multiple primary lung cancer; and (4) surgical treatment of locally resectable small cell lung cancer. Based on the Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition), this paper interprets the hot issues related to the surgical treatment of lung cancer.
